Are you impacted by the Stimate® Nasal Spray Recall?

There is a voluntary recall by Ferring Pharmaceuticals US of Stimate® (desmopressin acetate) Nasal Spray, 1.5 mg/ml, manufactured for CSL Behring by Ferring. Stimate nasal spray is used to treat some types of bleeding in people with von Willebrand disease (VWD) and mild to moderate Factor VIII deficiency.

Stimate® will not be resupplied until 2022

Simate alternative

large exclamation point
As reported by the National Hemophilia Foundation:1

Ferring Pharmaceuticals Inc. initiated a voluntary, consumer-level recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL, which is distributed and sold by CSL Behring LLC. At this time, Ferring does not anticipate resupply before 2022.

Are you currently taking Stimate® Nasal Spray—and looking for another option?

If you’ve been prescribed Stimate® nasal spray to treat bleeds associated with VWD or mild to moderate Factor VIII deficiency, we hope this recall will not severely impact your care. We understand the impact that a supply shortage, discontinuance, or interruption can have on patients, particularly those with a bleeding disorder. Octapharma reiterates the recommendations by the NHF and HFA—to contact your physician with any concerns about your treatment.

Wilate® is approved to treat all types of VWD bleeding and hemophilia A

Wilate is FDA approved to treat minor, moderate and severe bleeding in both children and adults with all types of VWD. Wilate is also approved in adolescents and adults with hemophilia A for routine prophylaxis and on-demand treatment and control of bleeding episodes.

Octapharma is committed to our patients and customers to offer a consistent and reliable product supply

With over a decade of real-world use, wilate is proven to be safe and effective for bleeding control in all types of VWD. To date, more than one billion units of wilate have been infused worldwide. To learn more, please use our Find a Rep locator to contact your local Octapharma representative to get answers to questions you may have about wilate.

References:
  1. National Hemophilia Foundation. CSL Behring States Stimate Will Not Be Resupplied until 2022. Published October 2, 2020. Accessed October 20, 2020. https://www.hemophilia.org/news/csl-behring-states-stimate-will-not-be-resupplied-until-2022